3/26
08:02 am
derm
Journey Medical (DERM) had its "buy" rating reaffirmed by HC Wainwright. They now have a $13.00 price target on the stock.
High
Report
Journey Medical (DERM) had its "buy" rating reaffirmed by HC Wainwright. They now have a $13.00 price target on the stock.